Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.
WuXi AppTec Co., Ltd. has announced an extraordinary general meeting (EGM) scheduled for September 23, 2025, to discuss and approve several resolutions. These include amendments to various company policies, the cancellation of the Supervisory Committee, changes to the registered capital, and the authorization for the Investment Department to manage trading shares. These proposed changes aim to streamline operations and enhance governance, potentially impacting the company’s strategic direction and stakeholder engagement.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company focuses on providing comprehensive research and development services to the pharmaceutical, biotechnology, and medical device industries.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
Learn more about 2359 stock on TipRanks’ Stock Analysis page.